Evidence map›Paper›PMID 28097374›Full record

ArticlePsychopharmacology2017

Effects of 5-HT

Paul J Fletcher, Fiona D Zeeb, Caleb J Browne, Guy A Higgins, Ashlie D Soko

Abstract read
PubMed Publisher
In one paragraph

Article in Psychopharmacology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.5field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. The anxiogenic drug yohimbine is a reinforcer in male and female rats.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2024
    Article
  3. Effects of psychedelic, DOI, on nucleus accumbens dopamine signaling to predictable rewards and cues in rats.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2024
    Article
  4. Review
  5. Article
  6. Effects of 5-HTAddiction biology · 2021
    Article
  7. Pharmacological evidence that 5-HTPsychopharmacology · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Paul J FletcherSection of Biopsychology and Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, 250 College Street, Toronto, ON, M5T 1R8, Canada. Paul.Fletcher@camh.ca.
Fiona D ZeebSection of Biopsychology and Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, 250 College Street, Toronto, ON, M5T 1R8, Canada.
Caleb J BrowneSection of Biopsychology and Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, 250 College Street, Toronto, ON, M5T 1R8, Canada.
Guy A HigginsDepartment of Pharmacology, University of Toronto, Toronto, Canada.
Ashlie D SokoSection of Biopsychology and Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, 250 College Street, Toronto, ON, M5T 1R8, Canada.
Centre for Addiction and Mental Health · CAUniversity of Toronto · CA

Funding

CIHR
6 · The paper itself

Abstract

objectivesThese experiments examined the effects of selective 5-HT

methodsWater-restricted rats learned to associate a conditioned stimulus (CS) with water in operant chambers. Subsequently, two response levers were made available; responding on one lever delivered the CS (now a CRf), while responding on the second lever had no consequences. The effects of agonist and antagonists of 5-HT

resultsResponding for a CRf was reduced by the agonists 8-OH-DPAT, DOI and Ro60-0175. 8-OH-DPAT also reduced responding for water and seemed to impair responding in a non-specific fashion. None of the receptor antagonists affected responding. Methylphenidate dose-dependently enhanced responding for a CRf, and this was attenuated by DOI and Ro60-0175. Conversely, the 5-HT

conclusionsNo evidence was found for a behaviourally selective effect of 5-HT

Indexed as

8-Hydroxy-2-(di-n-propylamino)tetralinAminopyridinesAmphetaminesAnimalsConditioning, OperantFluorobenzenesIndolesMaleMethylphenidatePiperazinesPiperidinesPyridinesRatsReceptor, Serotonin, 5-HT1AReceptor, Serotonin, 5-HT2AReceptor, Serotonin, 5-HT2C4-iodo-2,5-dimethoxyphenylisopropylamine6-chloro-5-methyl-1-((2-(2-methylpyrid-3-yloxy)pyrid-5-yl)carbamoyl)indoline8-Hydroxy-2-(di-n-propylamino)tetralinAminopyridinesAmphetaminesFluorobenzenesIndolesMethylphenidateN-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-N-(2-pyridinyl)cyclohexanecarboxamidePiperazinesPiperidinesPyridinesReceptor, Serotonin, 5-HT1AReceptor, Serotonin, 5-HT2AReceptor, Serotonin, 5-HT2CSerotonin 5-HT1 Receptor AgonistsSerotonin 5-HT1 Receptor AntagonistsSerotonin 5-HT2 Receptor AgonistsSerotonin 5-HT2 Receptor AntagonistsSerotonin AntagonistsSerotonin Receptor Agonistsvolinanserin5-HT1A receptors5-HT2A receptors5-HT2C receptorsConditioned reinforcerMethylphenidateSerotonin

Identifiers

PMID28097374
OpenAlexW2573873123

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.